{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:57:05Z","timestamp":1777510625372,"version":"3.51.4"},"reference-count":161,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.3892\/ijo.2017.4120","type":"journal-article","created":{"date-parts":[[2017,9,5]],"date-time":"2017-09-05T10:13:41Z","timestamp":1504606421000},"page":"1014-1024","source":"Crossref","is-referenced-by-count":14,"title":["Trophic and neurotrophic factors in human pituitary adenomas (Review)"],"prefix":"10.3892","volume":"51","author":[{"given":"Marialuisa","family":"Spoletini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samanta","family":"Taurone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Tombolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Minni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giancarlo","family":"Altissimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Venceslao","family":"Wierzbicki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felice","family":"Giangaspero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pier Paolo","family":"Parnigotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Artico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia","family":"Bardella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzo","family":"Agostinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco Saverio","family":"Pastore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,9,5]]},"reference":[{"key":"key20180107180332_b1-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/glia.20760","article-title":"Pituicyte modulation of neurohormone output","volume":"57","author":"Rosso","year":"2009","journal-title":"Glia"},{"key":"key20180107180332_b2-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0300-595X(85)80077-3","article-title":"Histopathology of the pituitary","volume":"14","author":"Doniach","year":"1985","journal-title":"Clin Endocrinol Metab"},{"key":"key20180107180332_b3-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1677\/JOE-09-0153","article-title":"Characterization of adherens junction protein expression and localization in pituitary cell networks","volume":"202","author":"Chauvet","year":"2009","journal-title":"J Endocrinol"},{"key":"key20180107180332_b4-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S1043-2760(01)00476-3","article-title":"A novel view of the function of pituitary folliculostellate cell network","volume":"12","author":"Stojilkovic","year":"2001","journal-title":"Trends Endocrinol Metab"},{"key":"key20180107180332_b5-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1210\/en.2004-1445","article-title":"Increased pituitary vascular endothelial growth factor-a in dopaminergic D2 receptor knockout female mice","volume":"146","author":"Cristina","year":"2005","journal-title":"Endocrinology"},{"key":"key20180107180332_b6-ijo-51-04-1014","first-page":"2129","article-title":"Lactotrophs: The new and major source for VEGF secretion and the influence of ECM on rat pituitary function in vitro","volume":"33","author":"Alfer","year":"2015","journal-title":"Oncol Rep"},{"key":"key20180107180332_b7-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/ijc.30628","article-title":"Complementary actions of dopamine D2 receptor agonist and anti-vegf therapy on tumoral vessel normalization in a transgenic mouse model","volume":"140","author":"Chauvet","year":"2017","journal-title":"Int J Cancer"},{"key":"key20180107180332_b8-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/EJE-15-0709","article-title":"History before diagnosis in childhood craniopharyngioma: Associations with initial presentation and long-term prognosis","volume":"173","author":"Hoffmann","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"key20180107180332_b9-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/cns.12709","article-title":"Pituicytoma-An outlook on possible targeted therapies","volume":"23","author":"Mende","year":"2017","journal-title":"CNS Neurosci Ther"},{"key":"key20180107180332_b10-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/02688697.2016.1181152","article-title":"Granular cell tumors in the central nervous system: A report on eight cases and a literature review","volume":"30","author":"Li","year":"2016","journal-title":"Br J Neurosurg"},{"key":"key20180107180332_b11-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3171\/2010.5.JNS1058","article-title":"Cystic granular cell tumor mimicking Rathke cleft cyst","volume":"114","author":"Mumert","year":"2011","journal-title":"J Neurosurg"},{"key":"key20180107180332_b12-ijo-51-04-1014","volume-title":"Pathology and pathogenesis of pituitary adenomas and other sellar lesions Endotext [Internet]","author":"Larkin","year":"2017"},{"key":"key20180107180332_b13-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/cncr.20412","article-title":"The prevalence of pituitary adenomas: A systematic review","volume":"101","author":"Ezzat","year":"2004","journal-title":"Cancer"},{"key":"key20180107180332_b14-ijo-51-04-1014","first-page":"1","article-title":"Tumors of the pituitary gland","volume-title":"Atlas of Tumor Pathology","author":"Asa","year":"1998"},{"key":"key20180107180332_b15-ijo-51-04-1014","first-page":"13071315","article-title":"Aggressive pituitary tumors","volume":"12","author":"Blevins","year":"1998","journal-title":"Oncology (Williston Park)"},{"key":"key20180107180332_b16-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/nrc926","article-title":"The pathogenesis of pituitary tumours","volume":"2","author":"Asa","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180107180332_b17-ijo-51-04-1014","first-page":"287","article-title":"Incidental pituitary macroadenoma: A population-based study","volume":"314","author":"Nammour","year":"1997","journal-title":"Am J Med Sci"},{"key":"key20180107180332_b18-ijo-51-04-1014","first-page":"1089","article-title":"Clinical review 45: Clinically nonfunctioning pituitary adenomas","volume":"76","author":"Katznelson","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107180332_b19-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1677\/ERC-08-0181","article-title":"Medical therapy for clinically non-functioning pituitary adenomas","volume":"15","author":"Colao","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"key20180107180332_b20-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.beem.2009.05.008","article-title":"The epidemiology and genetics of pituitary adenomas (Review)","volume":"23","author":"Daly","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key20180107180332_b21-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1677\/ERC-10-0018","article-title":"Differential gene expression profiles of invasive and non-invasive non-functioning pituitary adenomas based on microarray analysis","volume":"17","author":"Galland","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"key20180107180332_b22-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3389\/fendo.2015.00097","article-title":"Progress in the diagnosis and classification of pituitary adenomas","volume":"6","author":"Syro","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"key20180107180332_b23-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/(SICI)1097-0142(19960801)78:3<502::AID-CNCR18>3.0.CO;2-2","article-title":"The World Health Organization classification of adenohypophysial neoplasms. A proposed five-tier scheme","volume":"78","author":"Kovacs","year":"1996","journal-title":"Cancer"},{"key":"key20180107180332_b24-ijo-51-04-1014","first-page":"E4","article-title":"Genetics of pituitary adenomas: Current theories and future implications","volume":"19","author":"Jagannathan","year":"2005","journal-title":"Neurosurg Focus"},{"key":"key20180107180332_b25-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0959-437X(01)00259-3","article-title":"TGF-beta signaling: Positive and negative effects on tumorigenesis","volume":"12","author":"Wakefield","year":"2002","journal-title":"Curr Opin Genet Dev"},{"key":"key20180107180332_b26-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGFbeta in cancer (Review)","volume":"134","author":"Massagu\u00e9","year":"2008","journal-title":"Cell"},{"key":"key20180107180332_b27-ijo-51-04-1014","first-page":"3815","article-title":"Vascular endothelial growth inhibitor (VEGI) is an independent indicator for invasion in human pituitary adenomas","volume":"33","author":"Jia","year":"2013","journal-title":"Anticancer Res"},{"key":"key20180107180332_b28-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF02738884","article-title":"Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas","volume":"10","author":"Lloyd","year":"1999","journal-title":"Endocr Pathol"},{"key":"key20180107180332_b29-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/039463201202500114","article-title":"Neurotrophins, their receptors and KI-67 in human GH-secreting pituitary adenomas: An immunohistochemical analysis","volume":"25","author":"Artico","year":"2012","journal-title":"Int J Immunopathol Pharmacol"},{"key":"key20180107180332_b30-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tig.2003.11.003","article-title":"Acquiring signalling specificity from the cytokine receptor gp130","volume":"20","author":"Ernst","year":"2004","journal-title":"Trends Genet"},{"key":"key20180107180332_b31-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/365027a0","article-title":"Disruption of the CNTF gene results in motor neuron degeneration","volume":"365","author":"Masu","year":"1993","journal-title":"Nature"},{"key":"key20180107180332_b32-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/nm0602-620","article-title":"CNTF is a major protective factor in demyelinating CNS disease: A neurotrophic cytokine as modulator in neuroinflammation","volume":"8","author":"Linker","year":"2002","journal-title":"Nat Med"},{"key":"key20180107180332_b33-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1210\/edrv.18.2.0297","article-title":"Pituitary cytokine and growth factor expression and action","volume":"18","author":"Ray","year":"1997","journal-title":"Endocr Rev"},{"key":"key20180107180332_b34-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1210\/endo.141.5.7442","article-title":"The gp130 cytokines interleukin-11 and ciliary neurotropic factor regulate through specific receptors the function and growth of lactosomatotropic and folliculostellate pituitary cell lines","volume":"141","author":"Perez Castro","year":"2000","journal-title":"Endocrinology"},{"key":"key20180107180332_b35-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1677\/joe.0.1690539","article-title":"Effects of the gp130 cytokines ciliary neurotropic factor (CNTF) and interleukin-11 on pituitary cells: CNTF receptors on human pituitary adenomas and stimulation of prolactin and GH secretion in normal rat anterior pituitary aggregate cultures","volume":"169","author":"Perez Castro","year":"2001","journal-title":"J Endocrinol"},{"key":"key20180107180332_b36-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.it.2010.04.002","article-title":"TGF-beta and immune cells: An important regulatory axis in the tumor microenvironment and progression","volume":"31","author":"Yang","year":"2010","journal-title":"Trends Immunol"},{"key":"key20180107180332_b37-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11060-010-0399-y","article-title":"Analysis of transforming growth factor \u03b2 receptor expression and signaling in higher grade meningiomas","volume":"103","author":"Johnson","year":"2011","journal-title":"J Neurooncol"},{"key":"key20180107180332_b38-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ccr.2006.11.023","article-title":"High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene","volume":"11","author":"Bruna","year":"2007","journal-title":"Cancer Cell"},{"key":"key20180107180332_b39-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"e35684","DOI":"10.1371\/journal.pone.0035684","article-title":"Decreased levels of active SMAD2 correlate with poor prognosis in gastric cancer","volume":"7","author":"Wu","year":"2012","journal-title":"PLoS One"},{"key":"key20180107180332_b40-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/nrm3434","article-title":"TGF\u03b2 signalling in context","volume":"13","author":"Massagu\u00e9","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"key":"key20180107180332_b41-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/37284","article-title":"TGF-beta signalling from cell membrane to nucleus through SMAD proteins","volume":"390","author":"Heldin","year":"1997","journal-title":"Nature"},{"key":"key20180107180332_b42-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/39369","article-title":"Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling","volume":"389","author":"Nakao","year":"1997","journal-title":"Nature"},{"key":"key20180107180332_b43-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.2147\/OTT.S99699","article-title":"Smad3 and phospho-Smad3 are potential markers of invasive nonfunctioning pituitary adenomas","volume":"9","author":"Liu","year":"2016","journal-title":"Onco Targets Ther"},{"key":"key20180107180332_b44-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1530\/EJE-13-0081","article-title":"Transforming growth factor \u03b21 is not a reliable biomarker for valvular fibrosis but could be a potential serum marker for invasiveness of prolactinomas (pilot study)","volume":"169","author":"Elenkova","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"key20180107180332_b45-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1186\/s12885-015-1993-3","article-title":"TGF\u03b2 isoforms and receptors mRNA expression in breast tumours: Prognostic value and clinical implications","volume":"15","author":"Chen","year":"2015","journal-title":"BMC Cancer"},{"key":"key20180107180332_b46-ijo-51-04-1014","first-page":"2819","article-title":"MicroRNA-663 targets TGFB1 and regulates lung cancer proliferation","volume":"12","author":"Liu","year":"2011","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180107180332_b47-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13578-015-0064-4","article-title":"Hypoxia and TGF-\u03b21 lead to endostatin resistance by cooperatively increasing cancer stem cells in A549 transplantation tumors","volume":"5","author":"Wang","year":"2015","journal-title":"Cell Biosci"},{"key":"key20180107180332_b48-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1210\/endo.136.10.7664668","article-title":"Targeting of transforming growth factor-alpha expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas","volume":"136","author":"McAndrew","year":"1995","journal-title":"Endocrinology"},{"key":"key20180107180332_b49-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/mcne.1999.0754","article-title":"GDNF family neurotrophic factor signaling: Four masters, one servant?","volume":"13","author":"Airaksinen","year":"1999","journal-title":"Mol Cell Neurosci"},{"key":"key20180107180332_b50-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nrn812","article-title":"The GDNF family: Signalling, biological functions and therapeutic value","volume":"3","author":"Airaksinen","year":"2002","journal-title":"Nat Rev Neurosci"},{"key":"key20180107180332_b51-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1371\/journal.pbio.0050039","article-title":"Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system","volume":"5","author":"Kramer","year":"2007","journal-title":"PLoS Biol"},{"key":"key20180107180332_b52-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/382080a0","article-title":"Characterization of a multicomponent receptor for GDNF","volume":"382","author":"Treanor","year":"1996","journal-title":"Nature"},{"key":"key20180107180332_b53-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-9525(96)30113-3","article-title":"The GDNF-RET signalling partnership","volume":"13","author":"Robertson","year":"1997","journal-title":"Trends Genet"},{"key":"key20180107180332_b54-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1210\/endo.141.5.7548","article-title":"GDNF and RET-gene expression in anterior pituitary-cell types","volume":"141","author":"Urbano","year":"2000","journal-title":"Endocrinology"},{"key":"key20180107180332_b55-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1210\/jcem.87.4.8383","article-title":"Glial-derived neurotropic factor and RET gene expression in normal human anterior pituitary cell types and in pituitary tumors","volume":"87","author":"Jap\u00f3n","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107180332_b56-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2174\/156720207780637216","article-title":"The role of neurotrophins in axonal growth, guidance, and regeneration","volume":"4","author":"Lykissas","year":"2007","journal-title":"Curr Neurovasc Res"},{"key":"key20180107180332_b57-ijo-51-04-1014","first-page":"202","article-title":"Genetic modification of mesenchymal stem cells in spinal cord injury repair strategies","volume":"7","author":"Cui","year":"2013","journal-title":"Biosci Trends"},{"key":"key20180107180332_b58-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1007\/PL00000898","article-title":"Nerve growth factor: Structure and function","volume":"58","author":"Wiesmann","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"key20180107180332_b59-ijo-51-04-1014","first-page":"105","article-title":"The neuronal influence on tumor progression","volume":"1816","author":"Mancino","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"key20180107180332_b60-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1750-3639.2006.00037.x","article-title":"The dark side of the NGF family: Neurotrophins in neoplasias","volume":"16","author":"Kr\u00fcttgen","year":"2006","journal-title":"Brain Pathol"},{"key":"key20180107180332_b61-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3390\/cancers3010510","article-title":"Nerve growth factor in cancer cell death and survival","volume":"3","author":"Molloy","year":"2011","journal-title":"Cancers (Basel)"},{"key":"key20180107180332_b62-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1471-4159.1992.tb08451.x","article-title":"Expression of nerve growth factor and nerve growth factor receptor genes in human tissues and in prostatic adenocarcinoma cell lines","volume":"59","author":"MacGrogan","year":"1992","journal-title":"J Neurochem"},{"key":"key20180107180332_b63-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1158\/1078-0432.CCR-10-1890","article-title":"Brain-derived neurotrophic factor and neurotrophin-4\/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survival","volume":"17","author":"Vanhecke","year":"2011","journal-title":"Clin Cancer Res"},{"key":"key20180107180332_b64-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1021\/bi00859a043","article-title":"The isolation of the mouse nerve growth factor protein in a high molecular weight form","volume":"6","author":"Varon","year":"1967","journal-title":"Biochemistry"},{"key":"key20180107180332_b65-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1152\/physrev.1980.60.4.1284","article-title":"Physiology of nerve growth factor","volume":"60","author":"Thoenen","year":"1980","journal-title":"Physiol Rev"},{"key":"key20180107180332_b66-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1471-4159.2004.02360.x","article-title":"The nerve growth factor precursor proNGF exhibits neurotrophic activity but is less active than mature nerve growth factor","volume":"89","author":"Fahnestock","year":"2004","journal-title":"J Neurochem"},{"key":"key20180107180332_b67-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.semarthrit.2009.03.002","article-title":"Nerve growth factor in rheumatic diseases","volume":"40","author":"Seidel","year":"2010","journal-title":"Semin Arthritis Rheum"},{"key":"key20180107180332_b68-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"18424","DOI":"10.1074\/jbc.M109.007104","article-title":"Biological activity of nerve growth factor precursor is dependent upon relative levels of its receptors","volume":"284","author":"Masoudi","year":"2009","journal-title":"J Biol Chem"},{"key":"key20180107180332_b69-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.conb.2008.07.013","article-title":"Signaling by death receptors in the nervous system","volume":"18","author":"Haase","year":"2008","journal-title":"Curr Opin Neurobiol"},{"key":"key20180107180332_b70-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2006.12.018","article-title":"High affinity not in the vicinity?","volume":"53","author":"Barker","year":"2007","journal-title":"Neuron"},{"key":"key20180107180332_b71-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3835(01)00530-4","article-title":"Trk receptor tyrosine kinases: A bridge between cancer and neural development","volume":"169","author":"Nakagawara","year":"2001","journal-title":"Cancer Lett"},{"key":"key20180107180332_b72-ijo-51-04-1014","first-page":"890","article-title":"Importance of interaction between nerve growth factor and \u03b19\u03b21 integrin in glial tumor angiogenesis","volume":"14","author":"Walsh","year":"2012","journal-title":"Neurooncol"},{"key":"key20180107180332_b73-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/modpathol.3800542","article-title":"Distribution and significance of nerve growth factor receptor (NGFR\/p75NTR) in normal, benign and malignant breast tissue","volume":"19","author":"Reis-Filho","year":"2006","journal-title":"Mod Pathol"},{"key":"key20180107180332_b74-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/ijc.25508","article-title":"p75(NTR) induces apoptosis in medulloblastoma cells","volume":"128","author":"K\u00fcchler","year":"2011","journal-title":"Int J Cancer"},{"key":"key20180107180332_b75-ijo-51-04-1014","first-page":"353","article-title":"Nerve growth factor regulates dopamine D(2) receptor expression in prolactinoma cell lines via p75(NGFR)-mediated activation of nuclear factor-kappaB","volume":"16","author":"Fiorentini","year":"2002","journal-title":"Mol Endocrinol"},{"key":"key20180107180332_b76-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"17864","DOI":"10.1074\/jbc.M010499200","article-title":"Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways","volume":"276","author":"Descamps","year":"2001","journal-title":"J Biol Chem"},{"key":"key20180107180332_b77-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1210\/mend.14.1.0402","article-title":"Mitogenic effect of nerve growth factor (NGF) in LNCaP prostate adenocarcinoma cells: Role of the high- and low-affinity NGF receptors","volume":"14","author":"Sortino","year":"2000","journal-title":"Mol Endocrinol"},{"key":"key20180107180332_b78-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"37829","DOI":"10.1074\/jbc.M003146200","article-title":"Mediation of nerve growth factor-driven cell cycle arrest in PC12 cells by p53. Simultaneous differentiation and proliferation subsequent to p53 functional inactivation","volume":"275","author":"Hughes","year":"2000","journal-title":"J Biol Chem"},{"key":"key20180107180332_b79-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"30841","DOI":"10.1074\/jbc.270.52.30841","article-title":"Nerve growth factor-induced growth arrest and induction of p21Cip1\/WAF1 in NIH-3T3 cells expressing TrkA","volume":"270","author":"Decker","year":"1995","journal-title":"J Biol Chem"},{"key":"key20180107180332_b80-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ijc.10160","article-title":"Neurotrophin receptor p75(NTR) suppresses growth and nerve growth factor-mediated metastasis of human prostate cancer cells","volume":"98","author":"Krygier","year":"2002","journal-title":"Int J Cancer"},{"key":"key20180107180332_b81-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mc.10106","article-title":"Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor","volume":"36","author":"Khwaja","year":"2003","journal-title":"Mol Carcinog"},{"key":"key20180107180332_b82-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1014410519935","article-title":"Nerve growth factor plays a divergent role in mediating growth of rat C6 glioma cells via binding to the p75 neurotrophin receptor","volume":"56","author":"Weis","year":"2002","journal-title":"J Neurooncol"},{"key":"key20180107180332_b83-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"a001883","DOI":"10.1101\/cshperspect.a001883","article-title":"Tumor suppressive functions of p53","volume":"1","author":"Zilfou","year":"2009","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key20180107180332_b84-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1177\/1947601911408889","article-title":"Mutations in the p53 tumor suppressor gene: Important milestones at the various Steps of tumorigenesis","volume":"2","author":"Rivlin","year":"2011","journal-title":"Genes Cancer"},{"key":"key20180107180332_b85-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12022-007-9006-y","article-title":"P53 gene mutations in pituitary carcinomas","volume":"18","author":"Tanizaki","year":"2007","journal-title":"Endocr Pathol"},{"key":"key20180107180332_b86-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1073\/pnas.89.7.2764","article-title":"Pituitary hyperplasia induced by ectopic expression of nerve growth factor","volume":"89","author":"Borrelli","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107180332_b87-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor (Review)","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr Rev"},{"key":"key20180107180332_b88-ijo-51-04-1014","first-page":"519","article-title":"Vascular endothelial growth factor expression in pituitary adenomas","volume":"86","author":"Fukui","year":"2003","journal-title":"Acta Neurochir (Suppl)"},{"key":"key20180107180332_b89-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.humpath.2005.07.015","article-title":"Immunohistochemical analysis of tumor angiogenic factors in human pituitary adenomas","volume":"36","author":"Niveiro","year":"2005","journal-title":"Hum Pathol"},{"key":"key20180107180332_b90-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11060-004-6150-9","article-title":"Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space","volume":"74","author":"Pan","year":"2005","journal-title":"J Neurooncol"},{"key":"key20180107180332_b91-ijo-51-04-1014","first-page":"23","article-title":"Relationship between intratumoral hemorrhage and overexpression of vascular endothelial growth factor (VEGF) in pituitary adenoma","volume":"53","author":"Arita","year":"2004","journal-title":"Hiroshima J Med Sci"},{"key":"key20180107180332_b92-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"4243","DOI":"10.1046\/j.0953-816X.2000.01326.x","article-title":"Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk-1 receptor","volume":"12","author":"Sondell","year":"2000","journal-title":"Eur J Neurosci"},{"key":"key20180107180332_b93-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1200\/JCO.1995.13.2.477","article-title":"Tumor angiogenesis as a predictor of recurrence in gastric carcinoma","volume":"13","author":"Maeda","year":"1995","journal-title":"J Clin Oncol"},{"key":"key20180107180332_b94-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1677\/joe.0.1650483","article-title":"Vascular endothelial growth factor in the rat pituitary: Differential distribution and regulation by estrogen","volume":"165","author":"Ochoa","year":"2000","journal-title":"J Endocrinol"},{"key":"key20180107180332_b95-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/002215540205000410","article-title":"Expression and distribution of vascular endothelial growth factor receptor Flk-1 in the rat pituitary","volume":"50","author":"Vidal","year":"2002","journal-title":"J Histochem Cytochem"},{"key":"key20180107180332_b96-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jemt.10262","article-title":"Angiogenesis in pituitary adenomas","volume":"60","author":"Yamada","year":"2003","journal-title":"Microsc Res Tech"},{"key":"key20180107180332_b97-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1210\/jc.2002-020309","article-title":"Vascular endothelial growth factor, its receptor KDR\/Flk-1, and pituitary tumor transforming gene in pituitary tumors","volume":"87","author":"McCabe","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107180332_b98-ijo-51-04-1014","first-page":"253","article-title":"Overexpression of vascular endothelial growth factor164 and its co-receptor neuropilin-1 in estrogen-induced rat pituitary tumors and GH3 rat pituitary tumor cells","volume":"16","author":"Banerjee","year":"2000","journal-title":"Int J Oncol"},{"key":"key20180107180332_b99-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1385\/EP:16:2:115","article-title":"Expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor in pituitary adenomas","volume":"16","author":"Kim","year":"2005","journal-title":"Endocr Pathol"},{"key":"key20180107180332_b100-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1055\/s-2004-815722","article-title":"Estradiol stimulates vascular endothelial growth factor and interleukin-6 in human lactotroph and lactosomatotroph pituitary adenomas","volume":"112","author":"Onofri","year":"2004","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"key20180107180332_b101-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03345118","article-title":"Microvascular density and vascular endothelial growth factor expression in normal pituitary tissue and pituitary adenomas","volume":"26","author":"Viacava","year":"2003","journal-title":"J Endocrinol Invest"},{"key":"key20180107180332_b102-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s12022-010-9119-6","article-title":"VEGF and CD31 association in pituitary adenomas","volume":"21","author":"Cristina","year":"2010","journal-title":"Endocr Pathol"},{"key":"key20180107180332_b103-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1159\/000054675","article-title":"Vascular endothelial growth factor production and regulation in rodent and human pituitary tumor cells in vitro","volume":"74","author":"Lohrer","year":"2001","journal-title":"Neuroendocrinology"},{"key":"key20180107180332_b104-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1158\/1078-0432.CCR-07-1552","article-title":"Blocking vascular endothelial growth factor-A inhibits the growth of pituitary adenomas and lowers serum prolactin level in a mouse model of multiple endocrine neoplasia type 1","volume":"14","author":"Korsisaari","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107180332_b105-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"C1","DOI":"10.1530\/ERC-11-0297","article-title":"Hypoxia-induced VEGF production 'RSUMEs' in pituitary adenomas","volume":"19","author":"Fowkes","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"key20180107180332_b106-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1096\/fasebj.13.1.181","article-title":"VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo","volume":"13","author":"Zhai","year":"1999","journal-title":"FASEB J"},{"key":"key20180107180332_b107-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.4049\/jimmunol.178.7.4033","article-title":"The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells","volume":"178","author":"Prehn","year":"2007","journal-title":"J Immunol"},{"key":"key20180107180332_b108-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S1074-7613(02)00283-2","article-title":"TL1A is a TNF-like ligand for DR3 and TR6\/DcR3 and functions as a T cell costimulator","volume":"16","author":"Migone","year":"2002","journal-title":"Immunity"},{"key":"key20180107180332_b109-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.4049\/jimmunol.171.9.4868","article-title":"Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease","volume":"171","author":"Bamias","year":"2003","journal-title":"J Immunol"},{"key":"key20180107180332_b110-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10456-010-9195-8","article-title":"Vascular endothelial growth inhibitor (VEGI; TNFSF15) inhibits bone marrow-derived endothelial progenitor cell incorporation into Lewis lung carcinoma tumors","volume":"14","author":"Liang","year":"2011","journal-title":"Angiogenesis"},{"key":"key20180107180332_b111-ijo-51-04-1014","first-page":"1473","article-title":"Vascular endothelial growth inhibitor, expression in human prostate cancer tissue and the impact on adhesion and migration of prostate cancer cells in vitro","volume":"35","author":"Zhang","year":"2009","journal-title":"Int J Oncol"},{"key":"key20180107180332_b112-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10456-006-9033-1","article-title":"Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients","volume":"9","author":"Parr","year":"2006","journal-title":"Angiogenesis"},{"key":"key20180107180332_b113-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1038\/sj.onc.1203059","article-title":"VEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth","volume":"18","author":"Haridas","year":"1999","journal-title":"Oncogene"},{"key":"key20180107180332_b114-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s10456-013-9397-y","article-title":"Interferon-\u03b3 produced by tumor-infiltrating NK cells and CD4+ T cells downregulates TNFSF15 expression in vascular endothelial cells","volume":"17","author":"Lu","year":"2014","journal-title":"Angiogenesis"},{"key":"key20180107180332_b115-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/hh2401.101909","article-title":"Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor","volume":"89","author":"Yu","year":"2001","journal-title":"Circ Res"},{"key":"key20180107180332_b116-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-5793(00)02219-5","article-title":"Studies on the interaction between TWEAK and the death receptor WSL-1\/TRAMP (DR3)","volume":"485","author":"Kaptein","year":"2000","journal-title":"FEBS Lett"},{"key":"key20180107180332_b117-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0092-8674(01)00237-9","article-title":"The TNF and TNF receptor superfamilies: Integrating mammalian biology","volume":"104","author":"Locksley","year":"2001","journal-title":"Cell"},{"key":"key20180107180332_b118-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1073\/pnas.71.6.2295","article-title":"Purification of a growth factor for ovarian cells from bovine pituitary glands","volume":"71","author":"Gospodarowicz","year":"1974","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107180332_b119-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/me.2004-0182","article-title":"Pituitary tumor-derived fibroblast growth factor receptor 4 isoform disrupts neural cell-adhesion molecule\/N-cadherin signaling to diminish cell adhesiveness: A mechanism underlying pituitary neoplasia","volume":"18","author":"Ezzat","year":"2004","journal-title":"Mol Endocrinol"},{"key":"key20180107180332_b120-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1210\/edrv-8-2-95","article-title":"Structural characterization and biological functions of fibroblast growth factor","volume":"8","author":"Gospodarowicz","year":"1987","journal-title":"Endocr Rev"},{"key":"key20180107180332_b121-ijo-51-04-1014","first-page":"1436","article-title":"Identification and characterization of high molecular weight forms of basic fibroblast growth factor in human pituitary adenomas","volume":"75","author":"Li","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107180332_b122-ijo-51-04-1014","first-page":"1182","article-title":"Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1: Relation to pituitary tumor","volume":"76","author":"Zimering","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107180332_b123-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s12020-015-0802-8","article-title":"Locally produced estrogen through aromatization might enhance tissue expression of pituitary tumor transforming gene and fibroblast growth factor 2 in growth hormone-secreting adenomas","volume":"52","author":"Ozkaya","year":"2016","journal-title":"Endocrine"},{"key":"key20180107180332_b124-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/jcp.1041310118","article-title":"High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells","volume":"131","author":"Moscatelli","year":"1987","journal-title":"J Cell Physiol"},{"key":"key20180107180332_b125-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1096\/fasebj.6.15.1464370","article-title":"Complexity of FGF receptors: Genetic basis for structural diversity and functional specificity","volume":"6","author":"Givol","year":"1992","journal-title":"FASEB J"},{"key":"key20180107180332_b126-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1210\/jc.2003-031489","article-title":"Cytoplasmic expression of fibroblast growth factor receptor-4 in human pituitary adenomas: Relation to tumor type, size, proliferation, and invasiveness","volume":"89","author":"Qian","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107180332_b127-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/ijc.2910540305","article-title":"Amplification of fgfr4 gene in human breast and gynecological cancers","volume":"54","author":"Jaakkola","year":"1993","journal-title":"Int J Cancer"},{"key":"key20180107180332_b128-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/bjc.1995.420","article-title":"Expression of basic fibroblast growth factor and its receptor in human pancreatic carcinomas","volume":"72","author":"Ohta","year":"1995","journal-title":"Br J Cancer"},{"key":"key20180107180332_b129-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00008390-199708000-00004","article-title":"Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma","volume":"7","author":"Ahmed","year":"1997","journal-title":"Melanoma Res"},{"key":"key20180107180332_b130-ijo-51-04-1014","first-page":"1063","article-title":"Alterations in expression of basic fibroblast growth factor (FGF) 2 and its receptor FGFR-1 in human prostate cancer","volume":"5","author":"Giri","year":"1999","journal-title":"Clin Cancer Res"},{"key":"key20180107180332_b131-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/j.ajpath.2010.12.008","article-title":"Colorectal cancer cells activate adjacent fibroblasts resulting in FGF1\/FGFR3 signaling and increased invasion","volume":"178","author":"Henriksson","year":"2011","journal-title":"Am J Pathol"},{"key":"key20180107180332_b132-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1046\/j.1365-2265.2003.01598.x","article-title":"Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: Relationships to clinical tumour behaviour","volume":"58","author":"McCabe","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20180107180332_b133-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF02482452","article-title":"Subcellular localization of basic fibroblast growth factor and fibroblast growth factor receptor 1 in pituitary adenomas","volume":"19","author":"Fukui","year":"2002","journal-title":"Brain Tumor Pathol"},{"key":"key20180107180332_b134-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1158\/1078-0432.CCR-07-2003","article-title":"Fibroblast growth factor 2 and estrogen control the balance of histone 3 modifications targeting MAGE-A3 in pituitary neoplasia","volume":"14","author":"Zhu","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20180107180332_b135-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"e1002400","DOI":"10.1371\/journal.pgen.1002400","article-title":"The FGFR4-G388R polymorphism promotes mitochondrial STAT3 serine phosphorylation to facilitate pituitary growth hormone cell tumorigenesis","volume":"7","author":"Tateno","year":"2011","journal-title":"PLoS Genet"},{"key":"key20180107180332_b136-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.yexmp.2006.05.003","article-title":"The fibroblast growth factor receptor 4 (FGFR4) Arg388 allele correlates with survival in head and neck squamous cell carcinoma","volume":"82","author":"da Costa Andrade","year":"2007","journal-title":"Exp Mol Pathol"},{"key":"key20180107180332_b137-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/CEJ.0b013e3283457274","article-title":"Meta and pooled analyses of FGFR4 Gly388Arg polymorphism as a cancer prognostic factor","volume":"20","author":"Frullanti","year":"2011","journal-title":"Eur J Cancer Prev"},{"key":"key20180107180332_b138-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"5683","DOI":"10.1158\/0008-5472.CAN-12-2102","article-title":"The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy","volume":"72","author":"Serra","year":"2012","journal-title":"Cancer Res"},{"key":"key20180107180332_b139-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1093\/annonc\/mdq017","article-title":"FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer","volume":"21","author":"Marm\u00e9","year":"2010","journal-title":"Ann Oncol"},{"key":"key20180107180332_b140-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1210\/jcem.82.4.3896","article-title":"Altered expression of fibroblast growth factor receptors in human pituitary adenomas","volume":"82","author":"Abbass","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107180332_b141-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1172\/JCI14036","article-title":"Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis","volume":"109","author":"Ezzat","year":"2002","journal-title":"J Clin Invest"},{"key":"key20180107180332_b142-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/S0002-9440(10)63477-3","article-title":"Ikaros isoforms in human pituitary tumors: Distinct localization, histone acetylation, and activation of the 5\u2032 fibroblast growth factor receptor-4 promoter","volume":"163","author":"Ezzat","year":"2003","journal-title":"Am J Pathol"},{"key":"key20180107180332_b143-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1210\/me.2006-0223","article-title":"Targeting N-cadherin through fibroblast growth factor receptor-4: Distinct pathogenetic and therapeutic implications","volume":"20","author":"Ezzat","year":"2006","journal-title":"Mol Endocrinol"},{"key":"key20180107180332_b144-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/edrv-11-3-418","article-title":"Metabolism and effects of epidermal growth factor and related growth factors in mammals (Review)","volume":"11","author":"Fisher","year":"1990","journal-title":"Endocr Rev"},{"key":"key20180107180332_b145-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/300192a0","article-title":"Epidermal growth factor rapidly stimulates prolactin gene transcription","volume":"300","author":"Murdoch","year":"1982","journal-title":"Nature"},{"key":"key20180107180332_b146-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1073\/pnas.91.4.1500","article-title":"Heterodimerization of epidermal growth factor receptor and wild-type or kinase-deficient Neu: A mechanism of interreceptor kinase activation and transphosphorylation","volume":"91","author":"Qian","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107180332_b147-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/307521a0","article-title":"Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences","volume":"307","author":"Downward","year":"1984","journal-title":"Nature"},{"key":"key20180107180332_b148-ijo-51-04-1014","first-page":"48","article-title":"Epidermal growth factor receptor (EGFR) in lung cancer: An overview and update","volume":"2","author":"Bethune","year":"2010","journal-title":"J Thorac Dis"},{"key":"key20180107180332_b149-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/bjc.1991.30","article-title":"Epidermal growth factor receptor (EGFr); results of a 6 year follow-up study in operable breast cancer with emphasis on the node negative subgroup","volume":"63","author":"Nicholson","year":"1991","journal-title":"Br J Cancer"},{"key":"key20180107180332_b150-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-0-387-98094-2_10","article-title":"Activated epidermal growth factor receptor in ovarian cancer","volume":"149","author":"Hudson","year":"2009","journal-title":"Cancer Treat Res"},{"key":"key20180107180332_b151-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1542-3565(03)00219-2","article-title":"Expression of epidermal growth factor receptor in gastric carcinomas","volume":"1","author":"Takehana","year":"2003","journal-title":"Clin Gastroenterol Hepatol"},{"key":"key20180107180332_b152-ijo-51-04-1014","first-page":"656","article-title":"Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness","volume":"81","author":"LeRiche","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"key20180107180332_b153-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1210\/endo.135.5.7956924","article-title":"Expression of epidermal growth factor (EGF), its receptor, and related oncoprotein (erbB-2) in human pituitary tumors and response to EGF in vitro","volume":"135","author":"Chaidarun","year":"1994","journal-title":"Endocrinology"},{"key":"key20180107180332_b154-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/modpathol.3800118","article-title":"Analysis of epidermal growth factor receptor and activated epidermal growth factor receptor expression in pituitary adenomas and carcinomas","volume":"17","author":"Onguru","year":"2004","journal-title":"Mod Pathol"},{"key":"key20180107180332_b155-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1172\/JCI60417","article-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","volume":"121","author":"Fukuoka","year":"2011","journal-title":"J Clin Invest"},{"key":"key20180107180332_b156-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/330566a0","article-title":"Altered Gs and adenylate cyclase activity in human GH-secreting pituitary adenomas","volume":"330","author":"Vallar","year":"1987","journal-title":"Nature"},{"key":"key20180107180332_b157-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1677\/joe.1.05616","article-title":"Expression of epidermal growth factor receptor in neoplastic pituitary cells: Evidence for a role in corticotropinoma cells","volume":"183","author":"Theodoropoulou","year":"2004","journal-title":"J Endocrinol"},{"key":"key20180107180332_b158-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"M73","DOI":"10.1530\/EJE-15-0320","article-title":"Decoding the genetic basis of Cushing's disease: USP8 in the spotlight","volume":"173","author":"Theodoropoulou","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"key20180107180332_b159-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0079-6123(10)82009-6","article-title":"Pathogenesis of pituitary tumors","volume":"182","author":"Yu","year":"2010","journal-title":"Prog Brain Res"},{"key":"key20180107180332_b160-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1677\/joe.1.06992","article-title":"Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: Detection of a non-endothelial function of VEGF in pituitary tumours","volume":"191","author":"Onofri","year":"2006","journal-title":"J Endocrinol"},{"key":"key20180107180332_b161-ijo-51-04-1014","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1210\/jcem.85.3.6485","article-title":"Angiogenesis in pituitary adenomas and the normal pituitary gland","volume":"85","author":"Turner","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2019,10,3]],"date-time":"2019-10-03T04:21:16Z","timestamp":1570076476000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2017.4120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,5]]},"references-count":161,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2017,9,5]]},"published-print":{"date-parts":[[2017,10]]}},"alternative-id":["10.3892\/ijo.2017.4120"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2017.4120","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,5]]}}}